Last updated: 11/07/2018 16:42:51

Study Of Perennial Allergic Rhinitis

GSK study ID
FFR100688
See study documents
Clinicaltrials.gov ID
NCT00358475
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Completed
Completed
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Study of Perennial Allergic Rhinitis -Long term treatment study-
Trial description: This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.
Primary purpose:
Treatment
Trial design:
Single Group Assignment
Masking:
None (Open Label)
Allocation:
Non-randomized
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Drug: GW685698
Enrollment:
65
Observational study model:
Not applicable
Primary completion date:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Keisuke Masuyama, Yoriko Morioka, Terufumi Hara. Drug Use Investigation on Fluticasone Furoate (Allermist®) 27.5 µg 56 Metered Nasal Spray. Allergol Immunol. 2012;19(12):88-101.
Medical condition
Rhinitis, Allergic, Seasonal
Product
fluticasone furoate
Collaborators
Not applicable
Study date(s)
June 2005 to October 2005
Type
Interventional
Phase
3

Participation criteria

Sex
Female & Male
Age
16+ years
Accepts healthy volunteers
No
  • Informed consent.
  • Outpatient.
  • Significant concomitant medical condition.
  • Use of corticosteroids/allergy medications.
Inclusion and exclusion criteria
Inclusion criteria:
  • Informed consent.
  • Outpatient.
  • Diagnosis of perennial allergic rhinitis with symptoms.
  • Able to comply with study procedures.
Exclusion criteria:
  • Significant concomitant medical condition.
  • Use of corticosteroids/allergy medications.
  • Laboratory abnormality.
  • Positive pregnancy test.

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Unknown, Japan
Status
Study Complete
Contact us

Study documents

Scientific result summary
Available language(s): English
Download document(s)

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Completed
Actual primary completion date
Not applicable
Actual study completion date
2005-12-10

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website